162 related articles for article (PubMed ID: 36381793)
1. The Association Between Hair Loss and COVID-19: The Impact of Hair Loss After COVID-19 Infection on the Quality of Life Among Residents in Saudi Arabia.
Alkeraye S; Alrashidi A; Alotaibi NS; Almajli N; Alkhalifah B; Bajunaid N; Alharthi R; AlKaff T; Alharbi K
Cureus; 2022 Oct; 14(10):e30266. PubMed ID: 36381793
[TBL] [Abstract][Full Text] [Related]
2. Telogen effluvium and COVID-19: a cross-sectional study.
Aldahish A; Vasudevan R; Salem H; Alqahtani A; AlQasim S; Alqhatani A; Al Shahrani M; Al Mohsen L; Hajla M; Calina D; Sharifi-Rad J
Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7823-7830. PubMed ID: 37667959
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia.
Abdulwahab RA; Aldajani BM; Natto NK; Janabi AM; Alhijaili OI; Faqih NT; Alharbi A
Cureus; 2022 Sep; 14(9):e29285. PubMed ID: 36277546
[TBL] [Abstract][Full Text] [Related]
4. Telogen effluvium after COVID-19 vaccination among public in Saudi Arabia.
Alharbi M
J Family Med Prim Care; 2022 Oct; 11(10):6056-6060. PubMed ID: 36618187
[TBL] [Abstract][Full Text] [Related]
5. COVID-19-induced hair shedding and related risk factors: A Saudi perspective.
Bukhari AE; AlDosari DA; AlDosari MA; Muqrin RF; Moazin OM; Almutlq MM; Altalhab SM; Alharithy RS; Alkhalifah AI
J Family Med Prim Care; 2023 Dec; 12(12):3304-3311. PubMed ID: 38361868
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 infection is a major cause of acute telogen effluvium.
Sharquie KE; Jabbar RI
Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
Koç Yıldırım S; Erbağcı E; Demirel Öğüt N
J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647
[TBL] [Abstract][Full Text] [Related]
8. Determinants of Flu Vaccine Uptake Among the General Population in Saudi Arabia: A Study Based on the Health Belief Model.
Alsuwailem SI; Okmi EA; Alkhaldi EH; Almutairi KS; Alshamari WK
Cureus; 2023 Jul; 15(7):e41277. PubMed ID: 37533606
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of Alopecia Areata in Saudi Arabia: Cross-Sectional Descriptive Study.
Al-Ajlan A; Alqahtani ME; Alsuwaidan S; Alsalhi A
Cureus; 2020 Sep; 12(9):e10347. PubMed ID: 32923306
[TBL] [Abstract][Full Text] [Related]
10. [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].
Chávez-Chavira G
Rev Med Inst Mex Seguro Soc; 2023 Jul; 61(4):496-501. PubMed ID: 37540705
[TBL] [Abstract][Full Text] [Related]
11. The Effectiveness and Safety of Direct-Acting Antivirals in the Treatment of Hepatitis C Virus in Saudi Arabia: A Nationwide Study Based on the Saudi Ministry of Health Surveillance Data From 2017 to 2021.
Al-Ahmari TS; Alotaibi AF; Aljasser AI; Aljasser AI; Eldaw AM; Abd-Ellatif EE
Cureus; 2023 Aug; 15(8):e42780. PubMed ID: 37664260
[TBL] [Abstract][Full Text] [Related]
12. Quality of Life and the Presence of Depression Among Adults with Hair Loss in the South of Saudi Arabia.
Alomaish AR; Gosadi IM; Dallak FH; Darraj AI; Jaafari SM; Alshamakhy AE; Mleeh NT
Psychol Res Behav Manag; 2022; 15():1989-1996. PubMed ID: 35957760
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.
Seyfi S; Alijanpour R; Aryanian Z; Ezoji K; Mahmoudi M
J Med Life; 2022 May; 15(5):631-634. PubMed ID: 35815081
[TBL] [Abstract][Full Text] [Related]
14. The Use of Internet and Social Media for Health Information and Its Consequences Among the Population in Saudi Arabia.
AlMuammar SA; Noorsaeed AS; Alafif RA; Kamal YF; Daghistani GM
Cureus; 2021 Sep; 13(9):e18338. PubMed ID: 34722089
[TBL] [Abstract][Full Text] [Related]
15. Olfactory and Gustatory Dysfunctions Following COVID-19 Infection: Factors That Affect Their Duration in Saudi Arabia.
Hennawi YB; Alahmadi RA; AlOtaibi E; Alosaimi AN; Tashkandi GS; Saleem NE; Bukhari RI; Obaid M
Cureus; 2023 Apr; 15(4):e37317. PubMed ID: 37181970
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 induced telogen effluvium.
Aksoy H; Yıldırım UM; Ergen P; Gürel MS
Dermatol Ther; 2021 Nov; 34(6):e15175. PubMed ID: 34708909
[TBL] [Abstract][Full Text] [Related]
17. Persistent Smell Disorders After COVID-19 Infection and Their Impact on Quality of Life.
Fageeh YA; Altuwaireqi AS; Alghuraibi AB; Alotaibi MS; Alsulimany LE; Altooarki EA
Cureus; 2024 Apr; 16(4):e58469. PubMed ID: 38765373
[TBL] [Abstract][Full Text] [Related]
18. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.
Hussain N; Agarwala P; Iqbal K; Omar HMS; Jangid G; Patel V; Rathore SS; Kumari C; Velasquez-Botero F; López GAB; Vishwakarma Y; Nipu AP; Ahmed NK
J Med Virol; 2022 Apr; 94(4):1391-1401. PubMed ID: 34931698
[TBL] [Abstract][Full Text] [Related]
19. The Effect of the COVID-19 Vaccine on the Menstrual Cycle Among Reproductive-Aged Females in Saudi Arabia.
Alahmadi AM; Aljohani AH; Fadhloun RA; Almohammadi AS; Alharbi DF; Alrefai LS
Cureus; 2022 Dec; 14(12):e32473. PubMed ID: 36523858
[TBL] [Abstract][Full Text] [Related]
20. Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms.
Rossi A; Magri F; Sernicola A; Michelini S; Caro G; Muscianese M; Di Fraia M; Chello C; Fortuna MC; Grieco T
Skin Appendage Disord; 2021 Jul; 21(5):1-5. PubMed ID: 34373830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
